Clinical Trials · NCT01222598

A Study of Minirin Melt in Patients With Nocturia

Phase
N/A
Recruitment status
Completed
Sponsor
Ferring Pharmaceuticals
Enrollment
588
Start date
Sep 2008
Locations
37 sites, Czechia
Primary endpoint
Number of participants with adverse events
View Desmopressin compound reference